Melanoma Research Reagents | BRAF, PD-1, CTLA-4 Antibodies

Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+

Options

Confirm

Product types

0 selected

Proteins (75)

Assay Kit (419)

Antibodies (298)

Research Biosimilar (157)

Biosimilars (1)

Stable Cell Lines (1)
Expression system

0 selected

E. coli (35)

Mammalian Cells (186)

HEK293T (1)
Target

0 selected

Tocilizumab (3)

Inclacumab (1)

RBD (Omicron/BA.5) (3)

TRP-1 & CD134/OX40 (1)

Cergutuzumab (1)

Lorvotuzumab (1)

S100P (1)

Lintuzumab (1)

TPP17 (1)

Otilimab (1)

S100A6 (1)

Zagotenemab (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

M/Matrix protein (2)

CD274/PD-L1 & CD28 (1)

Figitumumab (1)

IDO1 (2)

Farletuzumab (1)

RBD (Delta Plus) (1)

Losatuxizumab (1)

Spike glycoprotein (RBD) (1)

S100A4 (3)

Epcoritamab (1)

S100A1 (2)

Imdevimab (1)

gC/UL44 (1)

Ibalizumab (1)

LAG-3 & PD-1 (1)

Sibrotuzumab (1)

Imlifidase (5)

RBD (6)

Codrituzumab (1)

Human β Amyloid (1-40) (1)

Rafivirumab (1)

Meplazumab (1)

Mirikizumab (2)

Vibecotamab (1)

Rosopatamab (2)

Omburtamab (1)

CD279/PD-1 & CD152/CTLA4 (4)

Toripalimab (1)

Tregalizumab (1)

S100A2 (1)

NP/Nucleoprotein (3)

Adalimumab (3)

Labetuzumab (1)

Elotuzumab (1)

CD152/CTLA4 & CD274/PD-L1 (1)

Faricimab (1)

TPP47 (1)

CD175/Tn (10)

Eculizumab (3)

Edrecolomab (1)

Tirzepatide (2)

Canakinumab (1)

Ganitumab (1)

Mirvetuximab (1)

S100A11 (2)

CD278/ICOS (1)

Semaglutide (2)

Necitumumab (1)

Zenocutuzumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

Glofitamab (1)

Ieramilimab (1)

gD/US6 (1)

Letolizumab (1)

Enfortumab (1)

RBD (Delta) (3)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

Dupilumab (3)

TAU pT181 (1)

Tibulizumab (1)

Sarilumab (2)

Abatacept (1)

Glembatumumab (1)

MITF (1)

Tarextumab (1)

MLANA (4)

Oxelumab (1)

Exenatide acetate (2)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

H3L (3)

CD223/LAG3 & CD152/CTLA4 (1)

CD79B (2)

CD274/PD-L1/B7-H1 (5)

Nirsevimab (1)

Benufutamab (1)

US8/gE (1)

Zanolimumab (1)

PD-L1 & TGF-Beta (1)

Lacnotuzumab (1)

PD-L1 / VEGF-A (1)

Olaratumab (1)

RBD (Omicron/JN.1) (1)

CD279/PD-1 & CD274/PD-L1 (1)

CD274/PD-L1 & TGFBR2 (1)

Tisotumab (1)

CD117/KIT (24)

RBD (WT) (1)

Oleclumab (1)

Nesvacumab (1)

G/Major surface glycoprotein G (1)

Milatuzumab (1)

PDL1 (6)

Befovacimab (1)

S100A8 (3)

Aflibercept (1)

GP/Envelope glycoprotein (4)

VSIR/VISTA & CD274/PD-L1 (1)

S100A12 (1)

Gevokizumab (1)

CD366/TIM-3 & CD274/PD-L1 (1)

Teprotumumab (1)

PDL1 & VEGF (1)

Bevacizumab (3)

Evolocumab (1)

Panitumumab (3)

EPO/Erythropoietin (1)

Ibritumomab (1)

Denosumab (3)

Palivizumab (3)

Simlukafusp Alfa (1)

Spike glycoprotein (10)

HLA-A2-peptide (YLEPGPVT) Complex (4)

CD152/CTLA4 & CD279/PD-1 (1)

Astegolimab (1)

TAU pT217 (1)

Vunakizumab (1)

Tosatoxumab (1)

Rituximab (1)

Alacizumab (1)

TYR (1)

Balstilimab (1)

Dilpacimab (1)

Frovocimab (1)

E8L (5)

S100a15a (1)

CD47/MER6 & CD274/PD-L1 (2)

cAMP (1)

Mosunetuzumab (1)

Cetuximab (3)

Mavezelimab (1)

Conatumumab (1)

Spike glycoprotein E2 (2)

Tovetumab (1)

CD80/B7-1 (20)

RBD (Omicron/KP.2) (1)

S100A14 (1)

Certolizumab (2)

Calprotectin (S100A8/9) (3)

Cabiralizumab (1)

RBD (Alpha) (1)

CD152/CTLA4 & CD134/OX40 (1)

Vanucizumab (1)

N/Nucleoprotein (1)

LAG3 & PD-1 (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

Concizumab (1)

TYR/Tyrosinase (2)

Rolinsatamab (1)

gG/US4 (2)

CD137/4-1BB & CD274/PD-L1 (3)

KITLG/SCF (1)

Brolucizumab (1)

Alirocumab (1)

Serclutamab (1)

S100B (9)

Clazakizumab (1)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

Afasevikumab (1)

Suptavumab (1)

CD20/MS4A1 (3)

Itolizumab (1)

Fluorescein & CD274/PD-L1 (1)

Ianalumab (1)

CD274/PD-L1 & SLT-Ia (1)

Spike Protein (Trimer) (2)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

Iscalimab (1)

Ramucirumab (1)

Cetrelimab (1)

Navicixizumab (1)

Bimagrumab (1)

Urelumab (1)

Lodelcizumab (1)

Retatrutide (1)

A35R (5)

HLA-A2-peptide (TDQVPFSV) Complex (1)

Ivuxolimab (1)

Olokizumab (1)

Ocaratuzumab (1)

sCD14 (1)

Favezelimab (1)

Drozitumab (1)

Spike glycoprotein E1 (2)

TIGIT & CD274/PD-L1 (1)

Eldelumab (1)

S100A9 (4)

Sacituzumab (1)

CD86/B7-2 (26)

CD3E (1)

CD340/ERBB2 (1)

CD274/PD-L1 & CD3E (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

Emactuzumab (1)

Imalumab (1)

RBD (Beta) (1)

Zampilimab (1)

Disitamab (1)

Marstacimab (1)

Natalizumab (2)

gB/Envelope glycoprotein B (1)

CD274/PD-L1 & CD279/PD-1 (1)

Basiliximab (1)

CD223 (1)

Apamistamab (1)

CTLA4 & PD1 (2)

Ranibizumab (3)

Pogalizumab (1)

cGMP (1)

Bimekizumab (1)

Mazdutide (2)

Amatuximab (1)

DCT (2)

CD274/PD-L1 & VEGFA (1)

NP/Nucleocapsid (5)

Asp f 1/mitF (1)

Belantamab (1)

Tiragolumab (2)

PMEL17/ME20M (9)

Obiltoxaximab (1)

FLT1/VEGFR1 & CD274/PD-L1 (1)

CD80&IL2 (1)

Nivolumab (3)

Atezolizumab (3)

Utomilumab (1)

β-D-Glucan (1)

A29L (6)

Tesidolumab (1)

Sirukumab (1)

TDP2 (1)

F/Fusion glycoprotein F0 (5)

Lexatumumab (1)

dsRNA (1)

BRAF/B-Raf (5)

VASH2/Vasohibin-2 (1)

Ipilimumab (2)

gp100 peptide-HLA Complex (1)

IL1RL1/ST2 (1)

CD274/PD-L1 & CD47/MER6 (1)

Golimumab (3)

CD366/TIM-3 (34)

RBD (Gamma) (1)

Lupartumab (1)

Pertuzumab (3)

CD223/LAG3 (41)

Anifrolumab (1)

gE/Envelope glycoprotein E (1)

CD366/TIM-3 & CD279/PD-1 (2)

Camidanlumab (1)

SOX10 (3)

Varisacumab (1)

Ustekinumab (3)

TRP-1 & CD3e (1)

IL6 (1)

Tavolimab (1)

BSA (1)

Ixekizumab (1)

Suvizumab (1)

Cusatuzumab (1)

Anetumab (1)

Blosozumab (1)

Varlilumab (1)

Teclistamab (1)

Ascrinvacumab (1)

Pembrolizumab (3)

TFF3 (1)

CD80/B7-1 & CD86/B7-2 (2)

Avelumab (3)

CD152/CTLA4 (86)

Daratumumab (3)

CD274/PD-L1 (81)

Tezepelumab (1)

B6R/SL-159 (1)

S100A13 (1)

mitF/aspF1 (1)

Ziltivekimab (1)

Carlumab (1)

Guselkumab (3)

Indatuximab (1)

Tigatuzumab (1)

ATP7B (1)

Lenzilumab (1)

Semorinemab (1)

Tremelimumab (1)

T3E (1)

dsDNA (1)

CD274/PD-L1 & CD134/OX40 (1)

CD19 & PD-L1 & CD3E & CD137 (1)

Cixutumumab (1)

Andecaliximab (1)

RBD (E484K) (1)

S100A16 (1)

Trastuzumab (2)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Obinutuzumab (2)

Sotrovimab (1)

gD/Envelope glycoprotein D (1)

EGFR & CD3E & PD-L1 & 4-1BB (1)

Daclizumab (1)

PD-L1 & VEGF (1)

Emibetuzumab (1)

Siltuximab (3)

Lirilumab (1)

Protein A (1)

Remtolumab (1)

NRAS (2)

CD274/PD-L1 & CD137/TNFRSF9 (1)

Vorsetuzumab (1)

Romosozumab (1)

Romiplostim (2)

TYRP1 (3)

S100A5 (4)

Enoblituzumab (1)

Gremubamab (1)

Omalizumab (2)

Sintilimab (1)

Durvalumab (3)

Magrolimab (1)

Crizanlizumab (1)

SARS-CoV-2 Neutralization Antibody (3)

TRP-1 & CD47/MER6 (1)

Tanezumab (1)

p-Tyr (1)

RBD (Omicron/BA.4/BA.5) (1)

TPP15 (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

Namilumab (1)

Tilavonemab (1)

Zalifrelimab (1)

S100A10 (4)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Glycoprotein (5)

Infliximab (2)

Dalotuzumab (1)

RBD (Kappa) (1)

Depatuxizumab (1)

Zanidatamab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Afutuzumab (1)

Casirivimab (1)

Icrucumab (1)

gC/Envelope glycoprotein C (1)

CD366/HAVCR2/TIM-3 (4)

Elezanumab (1)

Etanercept (3)

Human β Amyloid (1-42) (1)

Secukinumab (2)

Foravirumab (1)

Ontamalimab (1)

Talacotuzumab (1)

Pasotuxizumab (1)

Vofatamab (1)

Mirzotamab (1)

Glycoprotein G (2)

M1R (5)

CD274/PD-L1 & CD152/CTLA4 (1)

Cinpanemab (1)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Tislelizumab (1)

Pacmilimab (1)

CD223/LAG3 & CD279/PD-1 (4)

Ifabotuzumab (1)
Species

0 selected

Canis lupus familiaris (Dog) (8)

Rat (1)

Canis lupus familiaris (1)

Cat (1)

Mouse (27)

Human (178)

Mus musculus (Mouse) (7)

Tupaia chinensis (12)

Felis catus (Cat) (9)

Neosartorya fumigata (1)

Homo sapiens (Human) (7)

Dog (3)
Applications

0 selected

Research in vivo (158)

FACS (5)

in vitro PD-L1 blockade (3)

WB (165)

Research in vivo (4)

IFA (4)

in vivo blockade (2)

Functional assay (6)

IHC-F (3)

FuncS (18)

FCM (152)

GICA (2)

IF (8)

in vivo (2)

Blocking (2)

in vivo CTLA-4 neutralization (2)

Neut (1)

IP (2)

in vivo intra-tumoral regulatory T cell depletion (2)

Inhib (1)

SDS-PAGE (75)

Bioactivity: FACS (153)

Neutralization (2)

SPR (4)

Immunogen (75)

ELISA (844)

Functional assay (158)

in vivo PD-L1 blockade (3)

Bioactivity testing in progress (31)

IHC (84)

Bioactivity: FACS (1)
Reactivity

0 selected

Rat (16)

Rhesus macaque (1)

Kryptolebias marmoratus (1)

Bos taurus (8)

Mouse (78)

Limanda limanda (1)

Homo sapiens (Human) (4)

Carassius auratus (1)

Oryctolagus cuniculus (4)

Avian retrovirus IC10 (1)

Mesocricetus auratus (1)

Cavia porcellus (1)

Avian rous-associated virus type 1 (1)

Callithrix jacchus (1)

Monodelphis domestica (1)

Neosartorya fumigata (1)

Cyprinus carpio (1)

Capra hircus (1)

Human (198)

Coturnix japonica (1)

Oryzias latipes (1)

Bovine (1)

Danio rerio (1)

Xenopus laevis (1)

Cat (1)

Drosophila grimshawi (1)

Dog (13)

Broad-Spectrum (1)

Chicken (4)

Cynomolgus monkey (1)

Macaca mulatta (1)

B7-H1 / PD-L1 / CD274 (1)

Drosophila willistoni (1)

Pig (6)

Monkey (5)

Pongo abelii (2)

Tupaia chinensis (4)

Mus musculus (Mouse) (1)

Kirsten murine sarcoma virus (1)
Host species

0 selected

Armenian Hamster (5)

Rat (14)

Humanized (34)

Rabbit (61)

Dog (2)

Chimeric (5)

HEK293T (1)

Mouse (164)

Alpaca (6)

Human (157)
Clonality

0 selected

Polyclonal (53)

Monoclonal (398)
Conjugate

0 selected

FITC (28)

APC (28)

PerCP (28)

PE (28)

Unconjugated (301)